{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:49:45Z","timestamp":1788313785146,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81770056"],"award-info":[{"award-number":["81770056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013317","name":"Key Research and Development Project of Shanxi province","doi-asserted-by":"crossref","award":["2023-YBSF-405"],"award-info":[{"award-number":["2023-YBSF-405"]}],"id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03364-w","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:07:06Z","timestamp":1762520826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Harnessing NLRX1: a new frontier in mitigating inflammation in pulmonary hypertension"],"prefix":"10.1186","volume":"26","author":[{"given":"Yingchou","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengcai","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"3364_CR1","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1183\/09031936.00015608","volume":"32","author":"A Chaouat","year":"2008","unstructured":"Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32:1371\u201385.","journal-title":"Eur Respir J"},{"key":"3364_CR2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/01.RES.0000243584.45145.3f","volume":"99","author":"KR Stenmark","year":"2006","unstructured":"Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99:675\u201391.","journal-title":"Circ Res"},{"key":"3364_CR3","doi-asserted-by":"publisher","unstructured":"Hu Y, Chi L, Kuebler WM, Goldenberg NM. Perivascular inflammation in pulmonary arterial hypertension. Cells. 2020;9:2338. https:\/\/doi.org\/10.3390\/cells9112338.","DOI":"10.3390\/cells9112338"},{"key":"3364_CR4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1164\/rccm.201202-0335OC","volume":"186","author":"R Savai","year":"2012","unstructured":"Savai R, Pullamsetti SS, Kolbe J, Bieniek E, Voswinckel R, Fink L, Scheed A, Ritter C, Dahal BK, Vater A, et al. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:897\u2013908.","journal-title":"Am J Respir Crit Care Med"},{"key":"3364_CR5","doi-asserted-by":"publisher","unstructured":"Velloso FJ, Trombetta-Lima M, Anschau V, Sogayar MC, Correa RG. NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer. Biosci Rep. 2019;39:BSR20181709. https:\/\/doi.org\/10.1042\/BSR20181709.","DOI":"10.1042\/BSR20181709"},{"key":"3364_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nature06501","volume":"451","author":"CB Moore","year":"2008","unstructured":"Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, Zimmermann AG, Accavitti-Loper MA, Madden VJ, Sun L, Ye Z, et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature. 2008;451:573\u20137.","journal-title":"Nature"},{"key":"3364_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2011.02.022","volume":"34","author":"X Xia","year":"2011","unstructured":"Xia X, Cui J, Wang HY, Zhu L, Matsueda S, Wang Q, Yang X, Hong J, Songyang Z, Chen ZJ, Wang RF. NLRX1 negatively regulates TLR-induced NF-\u03baB signaling by targeting TRAF6 and IKK. Immunity. 2011;34:843\u201353.","journal-title":"Immunity"},{"key":"3364_CR8","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.4049\/jimmunol.1900364","volume":"203","author":"A Leber","year":"2019","unstructured":"Leber A, Hontecillas R, Zoccoli-Rodriguez V, Bienert C, Chauhan J, Bassaganya-Riera J. Activation of NLRX1 by NX-13 alleviates inflammatory bowel disease through immunometabolic mechanisms in CD4(+) T cells. J Immunol. 2019;203:3407\u201315.","journal-title":"J Immunol"},{"key":"3364_CR9","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.7150\/thno.43441","volume":"10","author":"JH Koo","year":"2020","unstructured":"Koo JH, Kim DH, Cha D, Kang MJ, Choi JM. LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis. Theranostics. 2020;10:3138\u201350.","journal-title":"Theranostics"},{"key":"3364_CR10","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.3389\/fimmu.2019.02419","volume":"10","author":"MA Nagai-Singer","year":"2019","unstructured":"Nagai-Singer MA, Morrison HA, Allen IC. NLRX1 is a multifaceted and enigmatic regulator of immune system function. Front Immunol. 2019;10:2419.","journal-title":"Front Immunol"},{"key":"3364_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13045-018-0573-9","volume":"11","author":"B Hu","year":"2018","unstructured":"Hu B, Ding GY, Fu PY, Zhu XD, Ji Y, Shi GM, Shen YH, Cai JB, Yang Z, Zhou J, et al. NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells. J Hematol Oncol. 2018;11:28.","journal-title":"J Hematol Oncol"},{"key":"3364_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.immuni.2011.03.026","volume":"34","author":"IC Allen","year":"2011","unstructured":"Allen IC, Moore CB, Schneider M, Lei Y, Davis BK, Scull MA, Gris D, Roney KE, Zimmermann AG, Bowzard JB, et al. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-\u03baB signaling pathways. Immunity. 2011;34:854\u201365.","journal-title":"Immunity"},{"key":"3364_CR13","doi-asserted-by":"publisher","first-page":"e3000451","DOI":"10.1371\/journal.pbio.3000451","volume":"17","author":"M Gharagozloo","year":"2019","unstructured":"Gharagozloo M, Mahmoud S, Simard C, Yamamoto K, Bobbala D, Ilangumaran S, Smith MD, Lamontagne A, Jarjoura S, Denault JB, et al. NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity. PLoS Biol. 2019;17:e3000451.","journal-title":"PLoS Biol"},{"key":"3364_CR14","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/ni.3853","volume":"18","author":"H Feng","year":"2017","unstructured":"Feng H, Lenarcic EM, Yamane D, Wauthier E, Mo J, Guo H, McGivern DR, Gonz\u00e1lez-L\u00f3pez O, Misumi I, Reid LM, et al. NLRX1 promotes immediate IRF1-directed antiviral responses by limiting dsRNA-activated translational Inhibition mediated by PKR. Nat Immunol. 2017;18:1299\u2013309.","journal-title":"Nat Immunol"},{"key":"3364_CR15","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1172\/JCI129497","volume":"130","author":"X Luo","year":"2020","unstructured":"Luo X, Donnelly CR, Gong W, Heath BR, Hao Y, Donnelly LA, Moghbeli T, Tan YS, Lin X, Bellile E, et al. HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING. J Clin Invest. 2020;130:1635\u201352.","journal-title":"J Clin Invest"},{"key":"3364_CR16","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1172\/JCI71747","volume":"125","author":"MJ Kang","year":"2015","unstructured":"Kang MJ, Yoon CM, Kim BH, Lee CM, Zhou Y, Sauler M, Homer R, Dhamija A, Boffa D, West AP, et al. Suppression of NLRX1 in chronic obstructive pulmonary disease. J Clin Invest. 2015;125:2458\u201362.","journal-title":"J Clin Invest"},{"key":"3364_CR17","doi-asserted-by":"publisher","first-page":"e1008854","DOI":"10.1371\/journal.ppat.1008854","volume":"16","author":"B Kastelberg","year":"2020","unstructured":"Kastelberg B, Tubau-Juni N, Ayubi T, Leung A, Leber A, Hontecillas R, Bassaganya-Riera J, Kale SD. NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis. PLoS Pathog. 2020;16:e1008854.","journal-title":"PLoS Pathog"},{"key":"3364_CR18","doi-asserted-by":"publisher","unstructured":"Sun W, Ding Y, Liu Z, Hou S, Sun D, Ma R, Kang H, Ma X, Wang J, Mu H, et al. Investigating the impact of HTNV infection on the gut microbiota of wild-type and NLRX1 knockout mice. Biochemical & Biophysical Research Communications. 2017;493:807\u201313. https:\/\/doi.org\/10.1016\/j.bbrc.2017.08.073.","DOI":"10.1016\/j.bbrc.2017.08.073"},{"key":"3364_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.104.492488","volume":"112","author":"Y Song","year":"2005","unstructured":"Song Y, Jones JE, Beppu H, Keaney JF Jr., Loscalzo J, Zhang YY. Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation. 2005;112:553\u201362.","journal-title":"Circulation"},{"key":"3364_CR20","doi-asserted-by":"publisher","unstructured":"Chen J, Zhang M, Liu Y, Zhao S, Wang Y, Wang M, Niu W, Jin F, Li Z. Histone lactylation driven by mROS-mediated glycolytic shift promotes hypoxic pulmonary hypertension. J Mol Cell Biol 2023, 14:mjac073 https:\/\/doi.org\/10.1093\/jmcb\/mjac073","DOI":"10.1093\/jmcb\/mjac073"},{"key":"3364_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1161\/HYPERTENSIONAHA.114.04600","volume":"65","author":"Y Luo","year":"2015","unstructured":"Luo Y, Dong HY, Zhang B, Feng Z, Liu Y, Gao YQ, Dong MQ, Li ZC. miR-29a-3p attenuates hypoxic pulmonary hypertension by inhibiting pulmonary adventitial fibroblast activation. Hypertension. 2015;65:414\u201320.","journal-title":"Hypertension"},{"key":"3364_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-7837-3_3","volume":"1784","author":"A Assouvie","year":"2018","unstructured":"Assouvie A, Daley-Bauer LP, Rousselet G. Growing murine bone Marrow-Derived macrophages. Methods Mol Biol. 2018;1784:29\u201333.","journal-title":"Methods Mol Biol"},{"key":"3364_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/15548627.2023.2274205","volume":"20","author":"Y Song","year":"2024","unstructured":"Song Y, Liang H, Li G, Ma L, Zhu D, Zhang W, Tong B, Li S, Gao Y, Wu X, et al. The NLRX1-SLC39A7 complex orchestrates mitochondrial dynamics and mitophagy to rejuvenate intervertebral disc by modulating mitochondrial Zn(2+) trafficking. Autophagy. 2024;20:809\u201329.","journal-title":"Autophagy"},{"key":"3364_CR24","doi-asserted-by":"publisher","first-page":"676782","DOI":"10.3389\/fphys.2021.676782","volume":"12","author":"K Pham","year":"2021","unstructured":"Pham K, Parikh K, Heinrich EC. Hypoxia and inflammation: insights from High-Altitude physiology. Front Physiol. 2021;12:676782.","journal-title":"Front Physiol"},{"key":"3364_CR25","doi-asserted-by":"publisher","unstructured":"Reyes-Garc\u00eda J, Carbajal-Garc\u00eda A, Di Mise A, Zheng YM, Wang X, Wang YX. Important functions and molecular mechanisms of mitochondrial redox signaling in pulmonary hypertension. Antioxid (Basel). 2022;11:473. https:\/\/doi.org\/10.3390\/antiox11030473.","DOI":"10.3390\/antiox11030473"},{"key":"3364_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","volume":"1865","author":"I Bellezza","year":"2018","unstructured":"Bellezza I, Giambanco I, Minelli A, Donato R. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta Mol Cell Res. 2018;1865:721\u201333.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3364_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jchf.2023.03.010","volume":"12","author":"M Okni\u0144ska","year":"2024","unstructured":"Okni\u0144ska M, Zajda K, Zambrowska Z, Grzanka M, Paterek A, Mackiewicz U, Szczylik C, Kurzyna M, Piekie\u0142ko-Witkowska A, Torbicki A, et al. Role of oxygen starvation in right ventricular decompensation and failure in pulmonary arterial hypertension. JACC Heart Fail. 2024;12:235\u201347.","journal-title":"JACC Heart Fail"},{"key":"3364_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/j.2040-4603.2011.tb00329.x","volume":"1","author":"T Tajsic","year":"2011","unstructured":"Tajsic T, Morrell NW. Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension. Compr Physiol. 2011;1:295\u2013317.","journal-title":"Compr Physiol"},{"key":"3364_CR29","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1378\/chest.08-0492","volume":"135","author":"HJ Bogaard","year":"2009","unstructured":"Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest. 2009;135:794\u2013804.","journal-title":"Chest"},{"key":"3364_CR30","doi-asserted-by":"publisher","first-page":"156055","DOI":"10.1016\/j.cyto.2022.156055","volume":"160","author":"M Liu","year":"2022","unstructured":"Liu M, Liu K, Cheng D, Zheng B, Li S, Mo Z. The regulatory role of NLRX1 in innate immunity and human disease. Cytokine. 2022;160:156055.","journal-title":"Cytokine"},{"key":"3364_CR31","doi-asserted-by":"publisher","first-page":"609812","DOI":"10.3389\/fcimb.2020.609812","volume":"10","author":"T Sn\u00e4k\u00e4","year":"2020","unstructured":"Sn\u00e4k\u00e4 T, Fasel N. Behind the scenes: Nod-Like receptor X1 controls inflammation and metabolism. Front Cell Infect Microbiol. 2020;10:609812.","journal-title":"Front Cell Infect Microbiol"},{"key":"3364_CR32","doi-asserted-by":"publisher","first-page":"102926","DOI":"10.1016\/j.redox.2023.102926","volume":"67","author":"CN Okoye","year":"2023","unstructured":"Okoye CN, Koren SA, Wojtovich AP. Mitochondrial complex I ROS production and redox signaling in hypoxia. Redox Biol. 2023;67:102926.","journal-title":"Redox Biol"},{"key":"3364_CR33","doi-asserted-by":"publisher","unstructured":"Nie X, Shen C, Tan J, Yang X, Wang W, Dai Y, Sun H, Wu Z, Chen J. Andrographolide attenuates established pulmonary hypertension via rescue of vascular remodeling. Biomolecules. 2021; 11:1801. https:\/\/doi.org\/10.3390\/biom11121801.","DOI":"10.3390\/biom11121801"},{"key":"3364_CR34","doi-asserted-by":"publisher","first-page":"155410","DOI":"10.1016\/j.phymed.2024.155410","volume":"126","author":"J Yang","year":"2024","unstructured":"Yang J, Zhang M, Luo Y, Xu F, Gao F, Sun Y, Yang B, Kuang H. Protopine ameliorates OVA-induced asthma through modulatingTLR4\/MyD88\/NF-\u03baB pathway and NLRP3 inflammasome-mediated pyroptosis. Phytomedicine. 2024;126:155410.","journal-title":"Phytomedicine"},{"key":"3364_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fimmu.2014.00169","volume":"5","author":"IC Allen","year":"2014","unstructured":"Allen IC. Non-Inflammasome forming NLRs in inflammation and tumorigenesis. Front Immunol. 2014;5:169.","journal-title":"Front Immunol"},{"key":"3364_CR36","doi-asserted-by":"publisher","unstructured":"Fekete T, Bencze D, B\u00edr\u00f3 E, Benk\u0151 S, P\u00e1zm\u00e1ndi K. Focusing on the cell type specific regulatory actions of NLRX1. Int J Mol Sci. 2021;22:1316. https:\/\/doi.org\/10.3390\/ijms22031316.","DOI":"10.3390\/ijms22031316"},{"key":"3364_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.micinf.2017.09.014","volume":"20","author":"SC Hung","year":"2018","unstructured":"Hung SC, Huang PR, Almeida-da-Silva CLC, Atanasova KR, Yilmaz O, Ojcius DM. NLRX1 modulates differentially NLRP3 inflammasome activation and NF-\u03baB signaling during Fusobacterium nucleatum infection. Microbes Infect. 2018;20:615\u201325.","journal-title":"Microbes Infect"},{"key":"3364_CR38","doi-asserted-by":"publisher","first-page":"e12986","DOI":"10.1111\/cpr.12986","volume":"54","author":"S Li","year":"2021","unstructured":"Li S, Zhou Y, Gu X, Zhang X, Jia Z. NLRX1\/FUNDC1\/NIPSNAP1-2 axis regulates mitophagy and alleviates intestinal ischaemia\/reperfusion injury. Cell Prolif. 2021;54:e12986.","journal-title":"Cell Prolif"},{"key":"3364_CR39","doi-asserted-by":"publisher","first-page":"119852","DOI":"10.1016\/j.bbamcr.2024.119852","volume":"1871","author":"K Mi","year":"2024","unstructured":"Mi K, Wang X, Ma C, Tan Y, Zhao G, Cao X, Yuan H. NLRX1 attenuates Endoplasmic reticulum stress via STING in cardiac hypertrophy. Biochim Biophys Acta Mol Cell Res. 2024;1871:119852.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3364_CR40","unstructured":"Atlas P. https:\/\/www.proteinatlas.org\/ENSG00000160703-NLRX1\/tissue\/lung"},{"key":"3364_CR41","doi-asserted-by":"publisher","first-page":"41637","DOI":"10.1074\/jbc.M110.137885","volume":"285","author":"AA Abdul-Sater","year":"2010","unstructured":"Abdul-Sater AA, Sa\u00efd-Sadier N, Lam VM, Singh B, Pettengill MA, Soares F, Tattoli I, Lipinski S, Girardin SE, Rosenstiel P, Ojcius DM. Enhancement of reactive oxygen species production and chlamydial infection by the mitochondrial Nod-like family member NLRX1. J Biol Chem. 2010;285:41637\u201345.","journal-title":"J Biol Chem"},{"key":"3364_CR42","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1128\/JVI.03039-13","volume":"88","author":"BL Unger","year":"2014","unstructured":"Unger BL, Ganesan S, Comstock AT, Faris AN, Hershenson MB, Sajjan US. Nod-like receptor X-1 is required for rhinovirus-induced barrier dysfunction in airway epithelial cells. J Virol. 2014;88:3705\u201318.","journal-title":"J Virol"},{"key":"3364_CR43","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41467-023-36629-3","volume":"14","author":"J S\u00e1-Pessoa","year":"2023","unstructured":"S\u00e1-Pessoa J, L\u00f3pez-Montesino S, Przybyszewska K, Rodr\u00edguez-Escudero I, Marshall H, Ova A, Schroeder GN, Barabas P, Molina M, Curtis T, et al. A trans-kingdom T6SS effector induces the fragmentation of the mitochondrial network and activates innate immune receptor NLRX1 to promote infection. Nat Commun. 2023;14:871.","journal-title":"Nat Commun"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03364-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03364-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03364-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:07:08Z","timestamp":1762520828000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03364-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3364"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03364-w","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocols in this research were sanctioned by the Institutional Animal Ethics and Use Committee of the Fourth Military Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"311"}}